These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8682723)

  • 1. Enzymatic 2'-N-acetylation of arbekacin and antibiotic activity of its product.
    Hotta K; Zhu CB; Ogata T; Sunada A; Ishikawa J; Mizuno S; Ikeda Y; Kondo S
    J Antibiot (Tokyo); 1996 May; 49(5):458-64. PubMed ID: 8682723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel enzymatic 3''-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of Streptomyces origin and the resulting activity.
    Hotta K; Sunada A; Ishikawa J; Mizuno S; Ikeda Y; Kondo S
    J Antibiot (Tokyo); 1998 Aug; 51(8):735-42. PubMed ID: 9766465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of aminoglycoside 6'-acetyltransferase in a novel multiple aminoglycoside resistance of an actinomycete strain #8: inactivation of aminoglycosides with 6'-amino group except arbekacin and neomycin.
    Zhu CB; Sunada A; Ishikawa J; Ikeda Y; Kondo S; Hotta K
    J Antibiot (Tokyo); 1999 Oct; 52(10):889-94. PubMed ID: 10604758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double stage activity in aminoglycoside antibiotics.
    Hotta K; Sunada A; Ikeda Y; Kondo S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1168-74. PubMed ID: 11132963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of multiple aminoglycoside resistance of kasugamycin-producing Streptomyces kasugaensis MB273: involvement of two types of acetyltransferases in resistance to astromicin group antibiotics.
    Hotta K; Ogata T; Ishikawa J; Okanishi M; Mizuno S; Morioka M; Naganawa H; Okami Y
    J Antibiot (Tokyo); 1996 Jul; 49(7):682-8. PubMed ID: 8784431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus].
    Kondo S
    Jpn J Antibiot; 1994 Jun; 47(6):561-74. PubMed ID: 8072163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
    Tabata M; Shimizu M; Araake M; Ogawa H
    Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
    Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Watanabe A
    Tohoku J Exp Med; 1998 Sep; 186(1):67-70. PubMed ID: 9915109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
    Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Hisamichi K; Mikami T; Watanabe A
    J Antimicrob Chemother; 1998 Apr; 41(4):495-7. PubMed ID: 9598784
    [No Abstract]   [Full Text] [Related]  

  • 10. Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus.
    Kondo S; Tamura A; Gomi S; Ikeda Y; Takeuchi T; Mitsuhashi S
    J Antibiot (Tokyo); 1993 Feb; 46(2):310-5. PubMed ID: 8468247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].
    Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y
    Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
    Suzuki T; Fujita K; Nagamachi Y; Okubo T
    Jpn J Antibiot; 1994 Jun; 47(6):634-9. PubMed ID: 8072171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1312-8. PubMed ID: 1479683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
    Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
    Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
    Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. novel 6'-n-aminoglycoside acetyltransferase AAC(6')-Iaj from a clinical isolate of Pseudomonas aeruginosa.
    Tada T; Miyoshi-Akiyama T; Shimada K; Shimojima M; Kirikae T
    Antimicrob Agents Chemother; 2013 Jan; 57(1):96-100. PubMed ID: 23070167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic 1-N-acetylation of paromomycin by an actinomycete strain #8 with multiple aminoglycoside resistance and paromomycin sensitivity.
    Sunada A; Nakajima M; Ikeda Y; Kondo S; Hotta K
    J Antibiot (Tokyo); 1999 Sep; 52(9):809-14. PubMed ID: 10726929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
    Ishii T; Takayama Y; Takase Y; Orikasa Y
    Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insights into translation inhibition by aminoglycoside antibiotic arbekacin.
    Parajuli NP; Mandava CS; Pavlov MY; Sanyal S
    Nucleic Acids Res; 2021 Jul; 49(12):6880-6892. PubMed ID: 34125898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.